Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on lowering androgen levels or blocking their activity, but many tumors eventually become resistant and ...
19 hours ago
0
3
Rare neuromuscular diseases often lack treatments because developing targeted drugs is slow, costly and risky for companies. A new approach using AI and stem cell models could finally shift the balance.
May 12, 2026
0
3
A new worm model developed by Brown University researchers could play a key role in treating a rare genetic disease that causes paralysis in children and worsens with age. Developed in the lab of neuroscientist Anne Hart, ...
22 hours ago
0
3
Diabetes is the most common and serious chronic disease worldwide, characterized by insufficient insulin to maintain proper blood glucose levels. It affects more than 12% of Americans and is the eighth leading cause of death ...
19 hours ago
0
3
World Health Organization chief Tedros Adhanom Ghebreyesus said on Tuesday "our work is not over" to contain hantavirus after evacuations from a cruise ship hit by a deadly outbreak of the illness.
5 hours ago
0
3
Predicting whether a healthy 45-year-old will struggle to climb stairs or walk a decade later has long been a challenge for geriatric medicine. Now, a study published in JMIR Aging, reveals that early mobility decline can ...
18 hours ago
0
3
Among opioid-related and non-opioid-related hospitalizations, amputation rates increased from 2016 to 2022, with greater increases seen among opioid-related hospitalizations nationally, according to a research letter published ...
14 hours ago
0
3
Researchers from some of the UK's leading academic institutions have warned that simply hiring more National Health service (NHS) staff will not be enough to reduce surgery backlogs, in research published in the Journal of ...
13 hours ago
0
3
The U.S. Food and Drug Administration has cleared ArteraAI Breast for use in patients with early-stage, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative invasive breast cancer.
19 hours ago
0
3
Implanting a device into the deep temporal cortex of a mouse without damaging the brain has long been a major challenge in neuroscience research. A team at Meijo University and Dokkyo Medical University has now overcome this ...
20 hours ago
0
3
